OCL-2A3 compositions and uses thereof
US8642549B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 8, 2008 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | Jul 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to osteoclast-specific genes and proteins. Specifically, the invention relates to OCL-2A3 or Atp6v0d2, the gene encoding it and uses thereof in methods and treatment of bone disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.